Novel Injectable Formulations

Allow for localization of a drug's effect, improving vaccine efficacy

• Prodrugs of IRMs show limited systemic exposure and cytokine release
• These compounds show enhanced adjuvant action as measured by increased CTL and Th1 activation
• Formulating IRMs to give depot effect also enhances vaccine efficacy and systemic tolerability

Contact Us for more information:

Contact Us